TQB3473 Tablets

DRUG2 trials

Sponsors

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Conditions

Primary Immune Thrombocytopenia

Phase 2

A Study on the Safety and Efficacy of TQB3473 Tablets in the Treatment of Persistent or Chronic Primary Immune Thrombocytopenia (ITP) in Adults

Not yet recruitingNCT07083739

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Primary Immune Thrombocytopenia

Start: 2025-08-31End: 2028-03-31Target: 320Updated: 2025-07-24

Phase 3

A Study of TQB3473 Tablets Compared to Placebo in the Treatment of Adult Primary Immune Thrombocytopenia

RecruitingNCT06900920

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Primary Immune Thrombocytopenia

Start: 2025-04-30End: 2027-12-31Target: 199Updated: 2025-05-20